- Home
- RGEN vs ONTO Comparison
RGEN vs ONTO Comparison
Compare RGEN & ONTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RGEN
- ONTO
- Stock Information
- Founded
- RGEN 1981
- ONTO 1940
- Country
- RGEN United States
- ONTO United States
- Employees
- RGEN N/A
- ONTO N/A
- Industry
- RGEN Medical/Dental Instruments
- ONTO Industrial Machinery/Components
- Sector
- RGEN Health Care
- ONTO Industrials
- Exchange
- RGEN Nasdaq
- ONTO Nasdaq
- Market Cap
- RGEN 6.5B
- ONTO 6.0B
- IPO Year
- RGEN N/A
- ONTO N/A
- Fundamental
- Price
- RGEN $152.80
- ONTO $134.64
- Analyst Decision
- RGEN Buy
- ONTO Strong Buy
- Analyst Count
- RGEN 11
- ONTO 7
- Target Price
- RGEN $167.90
- ONTO $148.57
- AVG Volume (30 Days)
- RGEN 972.1K
- ONTO 1.5M
- Earning Date
- RGEN 10-28-2025
- ONTO 10-30-2025
- Dividend Yield
- RGEN N/A
- ONTO N/A
- EPS Growth
- RGEN N/A
- ONTO 20.58
- EPS
- RGEN N/A
- ONTO 4.04
- Revenue
- RGEN $673,956,000.00
- ONTO $1,036,353,000.00
- Revenue This Year
- RGEN $16.77
- ONTO $2.90
- Revenue Next Year
- RGEN $13.79
- ONTO $8.96
- P/E Ratio
- RGEN N/A
- ONTO $33.17
- Revenue Growth
- RGEN 8.73
- ONTO 15.51
- 52 Week Low
- RGEN $102.97
- ONTO $85.88
- 52 Week High
- RGEN $182.52
- ONTO $228.42
- Technical
- Relative Strength Index (RSI)
- RGEN 65.63
- ONTO 56.28
- Support Level
- RGEN $143.47
- ONTO $131.54
- Resistance Level
- RGEN $157.03
- ONTO $136.86
- Average True Range (ATR)
- RGEN 6.17
- ONTO 7.28
- MACD
- RGEN 0.64
- ONTO -1.22
- Stochastic Oscillator
- RGEN 87.20
- ONTO 44.95
About RGEN Repligen Corporation
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the sources of total revenue.